Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Price:
614.78
USD
-1.08%
Market Closed
Market Cap:
$65B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
US |
|
I
|
IHI Corp
F:IWJ
|
JP |
|
First Majestic Silver Corp
TSX:FR
|
CA |
|
Chimera Investment Corp
NYSE:CIM
|
US |
|
Bark Inc
NYSE:BARK
|
US |
|
Z
|
ZJLD Group Inc
HKEX:6979
|
CN |
|
Puma SE
XETRA:PUM
|
DE |
|
Certara Inc
NASDAQ:CERT
|
US |
|
Synopsys Inc
NASDAQ:SNPS
|
US |
|
Covivio SA
F:F5D0
|
FR |
|
Noble Corp (Cayman Island)
NYSE:NE
|
US |
|
Booking Holdings Inc
NASDAQ:BKNG
|
US |
|
N
|
Nexon Co Ltd
TSE:3659
|
JP |
|
Hon Hai Precision Industry Co Ltd
TWSE:2317
|
TW |
|
Cigna Corp
NYSE:CI
|
US |
|
Netflix Inc
NASDAQ:NFLX
|
US |
|
NVR Inc
NYSE:NVR
|
US |
|
CETC Acoustic-Optic-Electronic Technology Inc
SSE:600877
|
CN |
|
HB Fuller Co
NYSE:FUL
|
US |
Multiples-Based Value
The Multiples-Based Value for Regeneron Pharmaceuticals Inc (REGN) under the Base Case is hidden
USD.
Compared with the current market price of 614.78 USD, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
REGN Multiples-Based Value
LOCKED
